Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.2%

16 terminated/withdrawn out of 257 trials

Success Rate

91.0%

+4.5% vs industry average

Late-Stage Pipeline

18 trials in Phase 3/4

Results Transparency

37%

60 of 161 completed trials have results

Key Signals

21 recruiting60 with results14 terminated

Enrollment Performance

Analytics

N/A

163(70.3%)

Phase 2

32(13.8%)

Phase 1

16(6.9%)

Phase 3

14(6.0%)

Phase 4

4(1.7%)

Early Phase 1

3(1.3%)

232Total

N/A(163)

Phase 2(32)

Phase 1(16)

Phase 3(14)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (257)

Showing 20 of 257 trials

NCT04701671Active Not Recruiting

Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids

Role: collaborator

NCT06854029Phase 4Not Yet Recruiting

NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

Role: collaborator

NCT04784585Not ApplicableActive Not Recruiting

Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment

Role: lead

NCT05161663Not ApplicableCompleted

A Peer-Driven Intervention to Increase PrEP Uptake Among Minority MSM

Role: lead

NCT06166225Not ApplicableActive Not Recruiting

Strategies for Improving Remote-based Weight Loss (PATH Trial)

Role: lead

NCT06878872Not ApplicableRecruiting

Type 1 Diabetes Adolescents for Healthier Lifestyles Study

Role: lead

NCT06654427Not ApplicableEnrolling By Invitation

Trauma-Informed Obstetric Care: Development and Implementation of a Toolkit for Obstetrics (OBTIC)

Role: lead

NCT06886789Not ApplicableRecruiting

SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation

Role: lead

NCT02656706Phase 2Active Not Recruiting

Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma

Role: collaborator

NCT04325321Not ApplicableCompleted

The Broken Heart Study II (BHS-II)

Role: lead

NCT03355976Phase 2Active Not Recruiting

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Role: collaborator

NCT05562427Not ApplicableActive Not Recruiting

Program for Fully Understanding Eating and Lifestyle Change (FUEL)

Role: lead

NCT05431192Not ApplicableRecruiting

Mind Your Heart-II

Role: lead

NCT05540704Not ApplicableRecruiting

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

Role: collaborator

NCT01859195Completed

Monoclonal Antibody-based Multipurpose Microbicides

Role: lead

NCT02744261Not ApplicableCompleted

Developing Rectal USPE Measures for Suppositories (Project DRUM-S)

Role: lead

NCT02102867Not ApplicableCompleted

Developing Rectal USPE Measures

Role: lead

NCT07228130Not ApplicableRecruiting

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

Role: lead

NCT06440278Not ApplicableActive Not Recruiting

Healthy Heart Habits-2

Role: lead

NCT07363616Not ApplicableRecruiting

Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight

Role: lead